Global Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Global Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines Market Size Growth Rate by Type
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaccines Market Size Growth Rate by Application
1.3.2 Rabies vaccine
1.3.3 Influenza vaccine
1.3.4 HPV vaccine
1.3.5 Hepatitis B
1.3.6 Hepatitis A
1.3.7 Leprosy vaccine
1.3.8 Polio vaccine
1.3.9 JE vaccine
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines Market Size Estimates and Forecasts
2.1.1 Global Vaccines Revenue 2016-2027
2.1.2 Global Vaccines Sales 2016-2027
2.2 Vaccines Market Size by Region: 2021 Versus 2027
2.3 Vaccines Sales by Region (2016-2027)
2.3.1 Global Vaccines Sales by Region: 2016-2021
2.3.2 Global Vaccines Sales Forecast by Region (2022-2027)
2.3.3 Global Vaccines Sales Market Share by Region (2016-2027)
2.4 Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Vaccines Revenue by Region: 2016-2021
2.4.2 Global Vaccines Revenue Forecast by Region (2022-2027)
2.4.3 Global Vaccines Revenue Market Share by Region (2016-2027)
3 Global Vaccines by Manufacturers
3.1 Global Top Vaccines Manufacturers by Sales
3.1.1 Global Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Vaccines Manufacturers by Revenue
3.2.1 Global Vaccines Revenue by Manufacturer (2016-2021)
3.2.2 Global Vaccines Revenue Share by Manufacturer (2016-2021)
3.3 Global Vaccines Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Vaccines Manufacturers Covered: Ranking by Revenue
3.4.2 Global Vaccines Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Vaccines Manufacturing Base Distribution, Product Type
3.5.1 Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Vaccines Product Type
3.5.3 Date of International Manufacturers Enter into Vaccines Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 GSK
4.1.1 GSK Corporation Information
4.1.2 GSK Description, Business Overview
4.1.3 GSK Vaccines Products Offered
4.1.4 GSK Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.1.5 GSK Vaccines Revenue by Product
4.1.6 GSK Vaccines Revenue by Application
4.1.7 GSK Vaccines Revenue by Geographic Area
4.1.8 GSK Vaccines Revenue by Sales Channel
4.1.9 GSK Recent Development
4.2 Sanofi
4.2.1 Sanofi Corporation Information
4.2.2 Sanofi Description, Business Overview
4.2.3 Sanofi Vaccines Products Offered
4.2.4 Sanofi Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Sanofi Vaccines Revenue by Product
4.2.6 Sanofi Vaccines Revenue by Application
4.2.7 Sanofi Vaccines Revenue by Geographic Area
4.2.8 Sanofi Vaccines Revenue by Sales Channel
4.2.9 Sanofi Recent Development
4.3 Merck
4.3.1 Merck Corporation Information
4.3.2 Merck Description, Business Overview
4.3.3 Merck Vaccines Products Offered
4.3.4 Merck Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Merck Vaccines Revenue by Product
4.3.6 Merck Vaccines Revenue by Application
4.3.7 Merck Vaccines Revenue by Geographic Area
4.3.8 Merck Vaccines Revenue by Sales Channel
4.3.9 Merck Recent Development
4.4 Pfizer
4.4.1 Pfizer Corporation Information
4.4.2 Pfizer Description, Business Overview
4.4.3 Pfizer Vaccines Products Offered
4.4.4 Pfizer Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Pfizer Vaccines Revenue by Product
4.4.6 Pfizer Vaccines Revenue by Application
4.4.7 Pfizer Vaccines Revenue by Geographic Area
4.4.8 Pfizer Vaccines Revenue by Sales Channel
4.4.9 Pfizer Recent Development
4.5 Novartis(GSK)
4.5.1 Novartis(GSK) Corporation Information
4.5.2 Novartis(GSK) Description, Business Overview
4.5.3 Novartis(GSK) Vaccines Products Offered
4.5.4 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Novartis(GSK) Vaccines Revenue by Product
4.5.6 Novartis(GSK) Vaccines Revenue by Application
4.5.7 Novartis(GSK) Vaccines Revenue by Geographic Area
4.5.8 Novartis(GSK) Vaccines Revenue by Sales Channel
4.5.9 Novartis(GSK) Recent Development
4.6 CSL
4.6.1 CSL Corporation Information
4.6.2 CSL Description, Business Overview
4.6.3 CSL Vaccines Products Offered
4.6.4 CSL Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.6.5 CSL Vaccines Revenue by Product
4.6.6 CSL Vaccines Revenue by Application
4.6.7 CSL Vaccines Revenue by Geographic Area
4.6.8 CSL Recent Development
4.7 MedImmune LLC
4.7.1 MedImmune LLC Corporation Information
4.7.2 MedImmune LLC Description, Business Overview
4.7.3 MedImmune LLC Vaccines Products Offered
4.7.4 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.7.5 MedImmune LLC Vaccines Revenue by Product
4.7.6 MedImmune LLC Vaccines Revenue by Application
4.7.7 MedImmune LLC Vaccines Revenue by Geographic Area
4.7.8 MedImmune LLC Recent Development
4.8 J&J(Crucell)
4.8.1 J&J(Crucell) Corporation Information
4.8.2 J&J(Crucell) Description, Business Overview
4.8.3 J&J(Crucell) Vaccines Products Offered
4.8.4 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.8.5 J&J(Crucell) Vaccines Revenue by Product
4.8.6 J&J(Crucell) Vaccines Revenue by Application
4.8.7 J&J(Crucell) Vaccines Revenue by Geographic Area
4.8.8 J&J(Crucell) Recent Development
4.9 China National Biotec
4.9.1 China National Biotec Corporation Information
4.9.2 China National Biotec Description, Business Overview
4.9.3 China National Biotec Vaccines Products Offered
4.9.4 China National Biotec Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.9.5 China National Biotec Vaccines Revenue by Product
4.9.6 China National Biotec Vaccines Revenue by Application
4.9.7 China National Biotec Vaccines Revenue by Geographic Area
4.9.8 China National Biotec Recent Development
4.10 Tiantan
4.10.1 Tiantan Corporation Information
4.10.2 Tiantan Description, Business Overview
4.10.3 Tiantan Vaccines Products Offered
4.10.4 Tiantan Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Tiantan Vaccines Revenue by Product
4.10.6 Tiantan Vaccines Revenue by Application
4.10.7 Tiantan Vaccines Revenue by Geographic Area
4.10.8 Tiantan Recent Development
4.11 Hualan
4.11.1 Hualan Corporation Information
4.11.2 Hualan Description, Business Overview
4.11.3 Hualan Vaccines Products Offered
4.11.4 Hualan Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Hualan Vaccines Revenue by Product
4.11.6 Hualan Vaccines Revenue by Application
4.11.7 Hualan Vaccines Revenue by Geographic Area
4.11.8 Hualan Recent Development
4.12 Kangtai
4.12.1 Kangtai Corporation Information
4.12.2 Kangtai Description, Business Overview
4.12.3 Kangtai Vaccines Products Offered
4.12.4 Kangtai Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Kangtai Vaccines Revenue by Product
4.12.6 Kangtai Vaccines Revenue by Application
4.12.7 Kangtai Vaccines Revenue by Geographic Area
4.12.8 Kangtai Recent Development
4.13 Hissen
4.13.1 Hissen Corporation Information
4.13.2 Hissen Description, Business Overview
4.13.3 Hissen Vaccines Products Offered
4.13.4 Hissen Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Hissen Vaccines Revenue by Product
4.13.6 Hissen Vaccines Revenue by Application
4.13.7 Hissen Vaccines Revenue by Geographic Area
4.13.8 Hissen Recent Development
4.14 Jintan
4.14.1 Jintan Corporation Information
4.14.2 Jintan Description, Business Overview
4.14.3 Jintan Vaccines Products Offered
4.14.4 Jintan Vaccines Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Jintan Vaccines Revenue by Product
4.14.6 Jintan Vaccines Revenue by Application
4.14.7 Jintan Vaccines Revenue by Geographic Area
4.14.8 Jintan Recent Development
5 Breakdown Data by Type
5.1 Global Vaccines Sales by Type (2016-2027)
5.1.1 Global Vaccines Sales by Type (2016-2021)
5.1.2 Global Vaccines Sales Forecast by Type (2022-2027)
5.1.3 Global Vaccines Sales Market Share by Type (2016-2027)
5.2 Global Vaccines Revenue Forecast by Type (2016-2027)
5.2.1 Global Vaccines Revenue by Type (2016-2021)
5.2.2 Global Vaccines Revenue Forecast by Type (2022-2027)
5.2.3 Global Vaccines Revenue Market Share by Type (2016-2027)
5.3 Vaccines Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Vaccines Sales by Application (2016-2027)
6.1.1 Global Vaccines Sales by Application (2016-2021)
6.1.2 Global Vaccines Sales Forecast by Application (2022-2027)
6.1.3 Global Vaccines Sales Market Share by Application (2016-2027)
6.2 Global Vaccines Revenue Forecast by Application (2016-2027)
6.2.1 Global Vaccines Revenue by Application (2016-2021)
6.2.2 Global Vaccines Revenue Forecast by Application (2022-2027)
6.2.3 Global Vaccines Revenue Market Share by Application (2016-2027)
6.3 Vaccines Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Vaccines Market Size YoY Growth 2016-2027
7.2 North America Vaccines Market Facts & Figures by Country
7.2.1 North America Vaccines Sales by Country (2016-2027)
7.2.2 North America Vaccines Revenue by Country (2016-2027)
7.3 North America Vaccines Sales by Type
7.4 North America Vaccines Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Vaccines Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Vaccines Market Facts & Figures by Region
8.2.1 Asia-Pacific Vaccines Sales by Region (2016-2027)
8.2.2 Asia-Pacific Vaccines Revenue by Region (2016-2027)
8.3 Asia-Pacific Vaccines Sales by Type
8.4 Asia-Pacific Vaccines Sales by Application
9 Europe
9.1 Europe Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Vaccines Market Facts & Figures by Country
9.2.1 Europe Vaccines Sales by Country (2016-2027)
9.2.2 Europe Vaccines Revenue by Country (2016-2027)
9.3 Europe Vaccines Sales by Type
9.4 Europe Vaccines Sales by Application
10 Latin America
10.1 Latin America Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Vaccines Market Facts & Figures by Country
10.2.1 Latin America Vaccines Sales by Country (2016-2027)
10.2.2 Latin America Vaccines Revenue by Country (2016-2027)
10.3 Latin America Vaccines Sales by Type
10.4 Latin America Vaccines Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Vaccines Sales by Country (2016-2027)
11.2.2 Middle East and Africa Vaccines Revenue by Country (2016-2027)
11.3 Middle East and Africa Vaccines Sales by Type
11.4 Middle East and Africa Vaccines Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Vaccines Supply Chain Analysis
12.2 Vaccines Key Raw Materials and Upstream Suppliers
12.3 Vaccines Clients Analysis
12.4 Vaccines Sales Channel and Sales Model Analysis
12.4.1 Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Vaccines Distributors
13 Market Dynamics
13.1 Vaccines Market Drivers
13.2 Vaccines Market Opportunities
13.3 Vaccines Market Challenges
13.4 Vaccines Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Recombinant Vaccines
Table 3. Major Manufacturers of Viral Vaccines
Table 4. Major Manufacturers of Polysaccharide Vaccines
Table 5. Major Manufacturers of Others
Table 6. Global Vaccines Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 7. Global Vaccines Market Size by Region (US$ Million): 2021 VS 2027
Table 8. Global Vaccines Sales by Region (2016-2021) & (K Pcs)
Table 9. Global Vaccines Sales Forecast by Region (2022-2027) & (K Pcs)
Table 10. Global Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Vaccines Sales by Manufacturer (2016-2021) & (K Pcs)
Table 13. Global Vaccines Sales Share by Manufacturer (2016-2021)
Table 14. Vaccines Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 15. Vaccines Revenue Share by Manufacturer (2016-2021)
Table 16. Key Manufacturers Vaccines Price (2016-2021) & (US$/Pcs)
Table 17. Ranking of Global Top Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 18. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccines as of 2020)
Table 20. Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Vaccines Product Type
Table 22. Date of International Manufacturers Enter into Vaccines Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. GSK Corporation Information
Table 25. GSK Description and Business Overview
Table 26. GSK Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 27. GSK Vaccines Product
Table 28. GSK Vaccines Revenue (US$ Million) and Market Share by Product
Table 29. GSK Vaccines Revenue (US$ Million) and Market Share by Application
Table 30. GSK Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 31. GSK Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 32. GSK Recent Development
Table 33. Sanofi Corporation Information
Table 34. Sanofi Description and Business Overview
Table 35. Sanofi Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 36. Sanofi Vaccines Product
Table 37. Sanofi Vaccines Revenue (US$ Million) and Market Share by Product
Table 38. Sanofi Vaccines Revenue (US$ Million) and Market Share by Application
Table 39. Sanofi Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 40. Sanofi Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 41. Sanofi Recent Development
Table 42. Merck Corporation Information
Table 43. Merck Description and Business Overview
Table 44. Merck Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 45. Merck Vaccines Product
Table 46. Merck Vaccines Revenue (US$ Million) and Market Share by Product
Table 47. Merck Vaccines Revenue (US$ Million) and Market Share by Application
Table 48. Merck Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 49. Merck Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 50. Merck Recent Development
Table 51. Pfizer Corporation Information
Table 52. Pfizer Description and Business Overview
Table 53. Pfizer Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 54. Pfizer Vaccines Product
Table 55. Pfizer Vaccines Revenue (US$ Million) and Market Share by Product
Table 56. Pfizer Vaccines Revenue (US$ Million) and Market Share by Application
Table 57. Pfizer Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 58. Pfizer Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 59. Pfizer Recent Development
Table 60. Novartis(GSK) Corporation Information
Table 61. Novartis(GSK) Description and Business Overview
Table 62. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 63. Novartis(GSK) Vaccines Product
Table 64. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Product
Table 65. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Application
Table 66. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 67. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 68. Novartis(GSK) Recent Development
Table 69. CSL Corporation Information
Table 70. CSL Description and Business Overview
Table 71. CSL Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 72. CSL Vaccines Product
Table 73. CSL Vaccines Revenue (US$ Million) and Market Share by Product
Table 74. CSL Vaccines Revenue (US$ Million) and Market Share by Application
Table 75. CSL Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 76. CSL Recent Development
Table 77. MedImmune LLC Corporation Information
Table 78. MedImmune LLC Description and Business Overview
Table 79. MedImmune LLC Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 80. MedImmune LLC Vaccines Product
Table 81. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Product
Table 82. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Application
Table 83. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 84. MedImmune LLC Recent Development
Table 85. J&J(Crucell) Corporation Information
Table 86. J&J(Crucell) Description and Business Overview
Table 87. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 88. J&J(Crucell) Vaccines Product
Table 89. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Product
Table 90. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Application
Table 91. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 92. J&J(Crucell) Recent Development
Table 93. China National Biotec Corporation Information
Table 94. China National Biotec Description and Business Overview
Table 95. China National Biotec Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 96. China National Biotec Vaccines Product
Table 97. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Product
Table 98. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Application
Table 99. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 100. China National Biotec Recent Development
Table 101. Tiantan Corporation Information
Table 102. Tiantan Description and Business Overview
Table 103. Tiantan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 104. Tiantan Vaccines Product
Table 105. Tiantan Vaccines Revenue (US$ Million) and Market Share by Product
Table 106. Tiantan Vaccines Revenue (US$ Million) and Market Share by Application
Table 107. Tiantan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 108. Tiantan Recent Development
Table 109. Hualan Corporation Information
Table 110. Hualan Description and Business Overview
Table 111. Hualan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 112. Hualan Vaccines Product
Table 113. Hualan Vaccines Revenue (US$ Million) and Market Share by Product
Table 114. Hualan Vaccines Revenue (US$ Million) and Market Share by Application
Table 115. Hualan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 116. Hualan Recent Development
Table 117. Kangtai Corporation Information
Table 118. Kangtai Description and Business Overview
Table 119. Kangtai Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 120. Kangtai Vaccines Product
Table 121. Kangtai Vaccines Revenue (US$ Million) and Market Share by Product
Table 122. Kangtai Vaccines Revenue (US$ Million) and Market Share by Application
Table 123. Kangtai Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 124. Kangtai Recent Development
Table 125. Hissen Corporation Information
Table 126. Hissen Description and Business Overview
Table 127. Hissen Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 128. Hissen Vaccines Product
Table 129. Hissen Vaccines Revenue (US$ Million) and Market Share by Product
Table 130. Hissen Vaccines Revenue (US$ Million) and Market Share by Application
Table 131. Hissen Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 132. Hissen Recent Development
Table 133. Jintan Corporation Information
Table 134. Jintan Description and Business Overview
Table 135. Jintan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 136. Jintan Vaccines Product
Table 137. Jintan Vaccines Revenue (US$ Million) and Market Share by Product
Table 138. Jintan Vaccines Revenue (US$ Million) and Market Share by Application
Table 139. Jintan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 140. Jintan Recent Development
Table 141. Global Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 142. Global Vaccines Sales Forecast by Type (2022-2027) & (K Pcs)
Table 143. Global Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 144. Global Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 145. Global Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 146. Global Vaccines Sales Forecast by Application (2022-2027) & (K Pcs)
Table 147. Global Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 148. Global Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 149. North America Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 150. North America Vaccines Sales by Country (2022-2027) & (K Pcs)
Table 151. North America Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 152. North America Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 153. North America Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 154. North America Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 155. Asia-Pacific Vaccines Sales by Region (2016-2021) & (K Pcs)
Table 156. Asia-Pacific Vaccines Sales by Region (2022-2027) & (K Pcs)
Table 157. Asia-Pacific Vaccines Revenue by Region (2016-2027) & (US$ Million)
Table 158. Asia-Pacific Vaccines Revenue by Region (2022-2027) & (US$ Million)
Table 159. Asia-Pacific Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 160. Asia-Pacific Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 161. Europe Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 162. Europe Vaccines Sales by Country (2022-2027) & (K Pcs)
Table 163. Europe Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 164. Europe Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 165. Europe Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 166. Europe Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 167. Latin America Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 168. Latin America Vaccines Sales by Country (2022-2027) & (K Pcs)
Table 169. Latin America Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 170. Latin America Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 171. Latin America Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 172. Latin America Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 173. Middle East and Africa Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 174. Middle East and Africa Vaccines Sales by Country (2022-2027) & (K Pcs)
Table 175. Middle East and Africa Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 176. Middle East and Africa Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 177. Middle East and Africa Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 178. Middle East and Africa Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 179. Vaccines Key Raw Materials, Industry Status and Trend
Table 180. Vaccines Key Raw Materials and Upstream Suppliers
Table 181. Vaccines Clients Status and Trend
Table 182. Vaccines Typical Clients
Table 183. Vaccines Distributors
Table 184. Key Drivers: Impact Analysis (2022-2027)
Table 185. Vaccines Market Drivers
Table 186. Vaccines Market Opportunities
Table 187. Vaccines Market Challenges
Table 188. Vaccines Market Restraints
Table 189. Vaccines Porter's Five Forces Analysis
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines Product Picture
Figure 2. Global Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Recombinant Vaccines Product Picture
Figure 4. Viral Vaccines Product Picture
Figure 5. Polysaccharide Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccines Sales Market Share by Application in 2021 & 2027
Figure 8. Rabies vaccine Examples
Figure 9. Influenza vaccine Examples
Figure 10. HPV vaccine Examples
Figure 11. Hepatitis B Examples
Figure 12. Hepatitis A Examples
Figure 13. Leprosy vaccine Examples
Figure 14. Polio vaccine Examples
Figure 15. JE vaccine Examples
Figure 16. Others Examples
Figure 17. Vaccines Report Years Considered
Figure 18. Global Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Vaccines Market Size 2016-2027 (US$ Million)
Figure 20. Global Vaccines Sales 2016-2027 (K Units)
Figure 21. Global Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 22. Global Vaccines Sales Market Share Forecast by Region (2016-2027)
Figure 23. Global Vaccines Revenue Market Share by Region (2016-2027)
Figure 24. Global Vaccines Sales Share by Manufacturer in 2020
Figure 25. Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Vaccines Sales Market Share Forecast by Type (2016-2027)
Figure 27. Global Vaccines Revenue Market Share Forecast by Type (2016-2027)
Figure 28. Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 29. Global Vaccines Sales Market Share Forecast by Application (2016-2027)
Figure 30. Global Vaccines Revenue Market Share Forecast by Application (2016-2027)
Figure 31. Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 32. North America Vaccines Revenue 2016-2027 (US$ Million)
Figure 33. North America Vaccines Sales Market Share by Type (2016-2021)
Figure 34. North America Vaccines Sales Market Share by Application (2016-2021)
Figure 35. Asia-Pacific Vaccines Revenue 2016-2027 (US$ Million)
Figure 36. Asia-Pacific Vaccines Sales Market Share by Region (2016-2027)
Figure 37. Asia-Pacific Vaccines Revenue Market Share by Region (2016-2027)
Figure 38. Asia-Pacific Vaccines Sales Market Share by Type (2016-2021)
Figure 39. Asia-Pacific Vaccines Sales Market Share by Application (2016-2021)
Figure 40. Europe Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 41. Europe Vaccines Sales Market Share by Country (2016-2027)
Figure 42. Europe Vaccines Revenue Market Share by Country (2016-2027)
Figure 43. Europe Vaccines Sales Market Share by Type (2016-2021)
Figure 44. Europe Vaccines Sales Market Share by Application (2016-2021)
Figure 45. Latin America Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 46. Latin America Vaccines Sales Market Share by Country (2016-2027)
Figure 47. Latin America Vaccines Revenue Market Share by Country (2016-2021)
Figure 48. Latin America Vaccines Sales Market Share by Type (2016-2021)
Figure 49. Latin America Vaccines Sales Market Share by Application (2016-2021)
Figure 50. Middle East and Africa Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 51. Middle East and Africa Vaccines Sales Market Share by Country (2016-2027)
Figure 52. Middle East and Africa Vaccines Revenue Market Share by Country (2016-2027)
Figure 53. Middle East and Africa Vaccines Sales Market Share by Type (2016-2021)
Figure 54. Middle East and Africa Vaccines Sales Market Share by Application (2016-2021)
Figure 55. Vaccines Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Vaccines Raw Materials by Region in 2020
Figure 57. Vaccines Distribution Channels
Figure 58. Global Vaccines Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 59. Global Vaccines Percentage 2016-2027: Online Sales VS Offline Sales
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs